CHICAGO, IL—Giving rivaroxaban (Xarelto; Bayer/Janssen) to adults under the age of 65, after an atrial fibrillation (AF) ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

Posters presented at the American Heart Association Scientific Sessions included results that show how persistent disparities ...

The NHS has raised the alarm over a “shocking” rise in strokes among the middle-aged that risk people being pushed out of ...

The first new guidelines in 10 years from the American Stroke Association for people and doctors reflect a better ...